Abstract
A major objective of research conducted by this investigator over the last 18 years has been to evaluate the pharmacological mechanisms by which nicotine can alter behavior, and the role that such mechanisms may have in the process of nicotine-induced dependence. The overall goals of this research have been to: (1) determine potential brain area sites of nicotine action important to its pharmacological effects; (2) determine whether nicotine is acting at cholinergic receptors (pre-or postsynaptic) excited (or inhibited) by the neurotransmitter acetylcholine (ACh); and (3) to determine the potential role that noncholinergic neurons play in the CNS pharmacology of nicotine. The overall approaches utilized in this research evolved from earlier research conducted by Domino (1) in which he very clearly showed that brain cholinergic neurons were not interdependent, as in the periphery, but existed as two independent receptor populations, muscarinic (M-Cholinergic; M-Ch) and nicotinic (N-Cholinergic; N-Ch).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Domino, EF: Neurophysiology of nicotine and tobacco smoking. In: (ed.) Dunn, WL, Jr, Smoking Behavior: Motives and Incentives. H. Winston and Sons, Washington, DC, pp. 5–31, 1973.
Hendry, JS and Rosecrans, JA: Effects of nicotine on conditioned and unconditioned behaviors in experimental animals. Pharmacol. Therap. 17:431–454, 1982.
Rosecrans, JA, Kallman, MJ and Glennon, R: The nicotine cue: An overview. In (ed.) Colpaert, FC and Rosecrans, JA, Stimulus Properties of Drugs: Ten Years of Progress. Elsevier Biomedical Press, Amsterdam, pp. 69–82, 1978.
Schechter, MD and Rosecrans, JA: CNS effect of nicotine as the discriminative stimulus for the rat in a T-maze. Life Sci. 10:821–832, 1971.
Hirschhorn, ID and Rosecrans, JA: Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine. Psychopharmacology 40:109–120, 1974.
Pratt, JA, Stolerman IP, Garcha, HS, Giardini, V, and Feyerabend, C: Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology 81:54–60, 1983.
Stolerman, IP, Garcha, HS, Pratt, JA and Kumar, R: Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413–419, 1984.
Rosecrans, JA and Meltzer, LT: Central sites and mechanisms of action of nicotine. Neurosci. Biobehav. Rev. 5:489–497, 1982.
Abood, LG, Lowy, K, Tometsko, A and Booth, H: Electrophysiological, behavioral and chemical evidence for a noncholinergic, stereospecific site for nicotine in rat brain. J. Neurosci. 3:327–333, 1978.
Nelsen, JM, Pelley, K and Goldstein, L: Protection by nicotine from behavioral disruption caused by reticular formation stimulation in the rat. Pharmacol. Biochem. Behav. 3:749–754, 1975.
Meltzer, LT, Rosecrans, JA, Aceto, MD and Harris, LS: Discriminative stimulus properties of the optical isomers of nicotine. Psychopharmacology 68:283–286, 1980.
Meltzer, LT and Rosecrans, JA: Investigations on the CNS sites of action of the discriminative stimulus effects of arecoline and nicotine. Pharmacol. Biochem. Behav. 15:21–26, 1981.
Rosecrans, JA, Dren, AT and Domino, EF: Effects of physostigmine on rat brain acetylcholine, acetylcholinesterase and conditioned pole jumping. Neuropharmacology 7:127–134, 1968.
Schwartz, RD, McGee, R and Kellar, KJ: Nicotinic cholinergic receptors labelled by [3H]acetylcholine in rat brain. Mol. Pharmacol. 22:56–62, 1982.
Kellar, KJ, Martino, AM, Hall, DP, Schwartz, RD and Taylor, RL: High-affinity binding of [3H]acetylcholine to muscarinic cholinergic receptors. J. Neurosci. 5:1577–1582, 1985.
Kessler, II, Parkinson’s disease. Perspectives on epidemiology and pathogenesis, In: Perspectives on Parkinson’s Disease, Academic Press, NY, pp. 88–105, 1973.
Kessler, II and Diamond, EL: Epidemiologic studies of Parkinson’s disease. I. Smoking and Parkinson’s disease: A survey and explanatory hypothesis. Amer. J. Epidemiol. 94:16–25, 1971.
Singer, G, Wallace, M and Hall, R: Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the rat. Pharmacol. Biochem. Behav. 17:579–581, 1982.
Rosecrans, JA, Chance, WT, Schechter, MD: The discriminative stimulus properties of nicotine, d-amphetamine and morphine in dopamine depleted rats. Psychopharmacol. Commun. 2:349–356, 1976.
Rosecrans, JA, Spencer, RM, Krynock, GM and Chance, WT: Discriminative properties of nicotine and nicotine-related compounds. In: (ed.) Battig, K, Behavioral Effects of Nicotine, Karger Press, Basel, pp. 70–82, 1978.
Robinson, SE, Malthe-Sorenssen, D, Wood, PL and Commissiong, J: Dopaminergic control of the septal-hippocampal cholinergic pathway. J. Pharmacol. Exp. Therap. 208:476–479, 1979.
Schwartz, RD, Lehmann, J and Kellar. KJ: Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain. J. Neurochem. 42:1495–1498, 1984.
Kallman, MJ, Harry, GJ, Elchisak, MA and Rosecrans, JA: Behavioral effects of chronic nicotine in adult rats depleted of dopamine. Fed. Proc. 45:428, 1986.
Hendry, JS and Rosecrans, JA: The development of pharmacological tolerance to the effect of nicotine on schedule-controlled responding in mice. Psychopharmacology 77:339–343, 1982.
Kellar, KJ and Schwartz, RD: In vivo regulation [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J. Neurochem. 45:427–433, 1985.
Meltzer, LT and Rosecrans, JA: Tolerance to the disruptive effects of arecoline on schedule-controlled behavior. Psychopharmacology 77:85–93, 1982.
Hendry, JS, Rosecrans, JA, Hong, J-S and Bondy, SC: Chronic nicotine reduces hypothalamic beta-endorphin in the mouse. Fed. Proc. 41:1077, 1982.
Rosecrans, JA., Hendry, JS and Hong, J-S: Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse. Pharmacol. Biochem. Behav. 23:141–143, 1985.
Botticelli, LJ and Wurtman, RJ: Septohippocampal cholinergic neurons are regulated trans-synaptically by endorphin and corticotrophin neuropeptides. J. Neurosci. 2:1316–1321, 1982.
Ross, JF and Grossman, SP: Intrahippocampal application of cholinergic agents and blockers. J. Comp. Physiol. Psychol. 86:590–600, 1974.
Segal, M: The acetylcholine receptor in the hippocampus: nicotinic, muscarinic or both? Neuropharmacology. 17:619–623, 1978.
Rovira, C, Cherubini, E and Ben-Ari, Y: Opposite actions of muscarinic and nicotinic agents on hippocampal dendritic negative fields recorded in rats. Neuropharmacology 22:239–243, 1983.
Robinson, SE: Effect of specific serotonergic lesions on cholinergic neurons in the hippocampus, cortex and striatum. Life Sci 32:345–353, 1983.
Glassman, AH, Jackson, WK, Walsh, BT and Roose, SP: Cigarette craving, smoking withdrawal, and clonidine. Science 226:864–866, 1984.
Goldberg, SR, Spealman, RD, Risner, ME and Hennigfield, JE: Control of behavior by intravenous nicotine injections in laboratory animals. Pharmacol. Biochem. Behav. 19:1011–1020, 1983.
Henningfield, JE and Goldberg, JR: Control of behavior by intravenous nicotine injections in human subjects. Pharmacol. Biochem. Behav. 19:1021–1026, 1983.
Kallman, WM, Kallman, MJ, Harry, GJ, Woodson, PP and Rosecrans, JA: Nicotine as a discriminative stimulus in human subjects. In: (ed.) Colpaert, FC and Slangen JL, Drug Discrimination: Application in CNS Pharmacology, Elsevier Biomedical Press, Amsterdam, pp. 211–218, 1982.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Rosecrans, J.A. (1987). Noncholinergic Mechanisms Involved in the Behavioral and Stimulus Effects of Nicotine, And Relationships to the Process of Nicotine Dependence. In: Martin, W.R., Van Loon, G.R., Iwamoto, E.T., Davis, L. (eds) Tobacco Smoking and Nicotine. Advances in Behavioral Biology, vol 31. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1911-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1911-5_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9063-6
Online ISBN: 978-1-4613-1911-5
eBook Packages: Springer Book Archive